These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38407254)

  • 21. Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.
    Mounkoro D; Nikiema CS; Maman I; Sakandé S; Bozio CH; Tall H; Sadji AY; Njanpop-Lafourcade BM; Sibabe A; Landoh DE; Abodji EO; Kodjo A; Tamekloe TA; Essoh TA; Maba DW; Gessner BD; Moïsi JC
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S216-S224. PubMed ID: 31671438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.
    Kourna Hama M; Khan D; Laouali B; Okoi C; Yam A; Haladou M; Worwui A; Ndow PS; Nse Obama R; Mwenda JM; Biey J; Ntsama B; Kwambana-Adams BA; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S133-S139. PubMed ID: 31505636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175)
    Lamelas A; Hauser J; Dangy JP; Hamid AM; Röltgen K; Abdul Sater MR; Hodgson A; Sie A; Junghanss T; Harris SR; Parkhill J; Bentley SD; Pluschke G
    Microb Genom; 2017 Aug; 3(8):e000120. PubMed ID: 29026659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.
    Njanpop-Lafourcade BM; Parent du Châtelet I; Sanou O; Alonso JM; Taha MK
    Microbes Infect; 2005 Apr; 7(4):645-9. PubMed ID: 15823512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.
    Topaz N; Caugant DA; Taha MK; Brynildsrud OB; Debech N; Hong E; Deghmane AE; Ouédraogo R; Ousmane S; Gamougame K; Njanpop-Lafourcade BM; Diarra S; Fox LM; Wang X
    EBioMedicine; 2019 Mar; 41():488-496. PubMed ID: 30846392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
    Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Sadji AY; Poy AN; Lingani C; Tall H; Sakandé S; Tarbangdo F; Aké F; Mbaeyi SA; Moïsi J; Paye MF; Sanogo YO; Vuong JT; Wang X; Ronveaux O; Novak RT;
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S165-S174. PubMed ID: 31671441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
    Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007.
    Rose AM; Mueller JE; Gerstl S; Njanpop-Lafourcade BM; Page AL; Nicolas P; Traoré RO; Caugant DA; Guerin PJ
    PLoS One; 2010 Jun; 5(6):e11086. PubMed ID: 20552035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The Neisseria meningitidis W135 epidemic in 2012 in Burkina Faso].
    Savadogo M; Kyélem N; Yélbéogo D; Koussoubé D; Tarbagdo F; Ouédraogo A
    Bull Soc Pathol Exot; 2014 Feb; 107(1):15-7. PubMed ID: 24363014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.
    Taha MK; Parent Du Chatelet I; Schlumberger M; Sanou I; Djibo S; de Chabalier F; Alonso JM
    J Clin Microbiol; 2002 Mar; 40(3):1083-4. PubMed ID: 11880446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
    Caugant DA; Kristiansen PA; Wang X; Mayer LW; Taha MK; Ouédraogo R; Kandolo D; Bougoudogo F; Sow S; Bonte L
    PLoS One; 2012; 7(9):e46019. PubMed ID: 23029368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.
    Sié A; Pflüger V; Coulibaly B; Dangy JP; Kapaun A; Junghanss T; Pluschke G; Leimkugel J
    Trop Med Int Health; 2008 Jun; 13(6):861-8. PubMed ID: 18384478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study.
    Azure S; Abdul-Karim A; Abubakari BB; Eleeza JB; Agboyie DDA; Weyori EW; Choi JY
    BMC Infect Dis; 2023 Apr; 23(1):202. PubMed ID: 37024833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Frequency Changes in Pilin Glycosylation Patterns during
    Jen FE; Abrahams JL; Schulz BL; Lamelas A; Pluschke G; Jennings MP
    ACS Infect Dis; 2023 Aug; 9(8):1451-1457. PubMed ID: 37467082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
    Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
    Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria.
    Uadiale K; Bestman A; Kamau C; Caugant DA; Greig J
    Trans R Soc Trop Med Hyg; 2016 Jul; 110(7):381-5. PubMed ID: 27496511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.
    Mbaeyi S; Sampo E; Dinanibè K; Yaméogo I; Congo-Ouédraogo M; Tamboura M; Sawadogo G; Ouattara K; Sanou M; Kiemtoré T; Dioma G; Sanon B; Somlaré H; Kyetega A; Ba AK; Aké F; Tarbangdo F; Aboua FA; Donnou Y; Kamaté I; Patel JC; Schmink S; Spiller MW; Topaz N; Novak R; Wang X; Bicaba B; Sangaré L; Ouédraogo-Traoré R; Kristiansen PA
    Lancet Infect Dis; 2020 Dec; 20(12):1418-1425. PubMed ID: 32653071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):612-7. PubMed ID: 29028166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.